Progress In Cancer Drug Lifts Merck Earnings, Sending Stock Higher

ForbesProgress In Cancer Drug Lifts Merck Earnings, Sending Stock HigherForbesBut because the company's ultimate profit and revenue results were above what Wall Street was expecting to see — and because sales were helped by a promising new cancer drug -- shares of Merck are trading higher in early Tuesday trading.and more »

Share this post